Prof. Dr. med. Ulrich Alfons Müller: Müller / Egidi / Klinge / Wolf (Hrsg.), 2021, ELSEVIER ESSENTIALS Diabetes – Das Wichtigste für Ärztinnen und Ärzte aller
Fachrichtungen
Müller N, Lehmann T, Klöss A, Günster C, Kloos C, Müller UA. Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication. Diabet Med. 2020 Mar 7.
Busch M, Lehmann T, Wolf G, Günster C, Müller UA, Müller N. Antidiabetic Therapy and Rate of Severe Hypoglycaemia in Patients with Type 2 Diabetes and Chronic Kidney Disease of Different Stages – A Follow-up Analysis of Health Insurance Data from Germany. Exp Clin Endocrinol Diabetes. 2020 Apr 14.
Werner C, Lupp A, Mtuka-Pardon G, Kloos C, Wolf G, Aschenbach R, Biermann A, Freesmeyer M, Seifert P. Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC Endocr Disord. 2020 Apr 20;20(1):53.
Jacob VYP, Felber J, Müller N, Kloos C, Müller UA, Stallmach A. The High-Resolution Three-Dimensional Magnetic Detector System 3D-Magma Accurately Measures Gastric and Small Bowel Motility in People with Type 2 Diabetes with Neuropathy. Exp Clin Endocrinol Diabetes. 2020 Jun 18.
Gerdes C, Werner C, Kloos C, Lehmann T, Wolf G, Müller UA, Müller N. Progression of Diabetic Complications in Subgroups of People with Long Term Diabetes Type 1 According to Clinical Course. Exp Clin Endocrinol Diabetes. 2020 Aug 10.
Keinki C, Meyer H, Bozkurt G, Müller N, Römelt J, Müller UA, Hübner J. Salvation Expectations of Patients of Medicine, Complementary and Alternative Medicine and Religion. J Relig Health. 2020 Sep 18.
Spraul A, Schönbach AM, Müller N, Müller UA, Koller A, Spraul M. Long-term outcome of persons with diabetic and non-diabetic neuro-osteoarthropathy after foot correction using external fixation. Diabet Med. 2020 Sep 18:e14404.
Heller T, Kloos C, Müller N, Roemelt J, Keinki C, Wolf G, Müller UA, Hübner J. Complementary and alternative medicine is positively associated with religiousness/spirituality. J Complementary Integr Med 2020 Jun 22;/j/jcim.ahead-of-print/jcim-2018-0023/jcim-2018-0023.xml.
Horvath LB, Müller N, Kuniß N, Bleidorn J, Schulz S. – Gründe für die Nicht-Teilnahme von Diabetespatient*innen an einer strukturierten Schulung: ein narrativer Review. Z Allg Med. 2021;97:26-31
Kramer G, Michalak L, Müller UA, Kloos C, Werner C, Kuniss N. Association between Flash Glucose Monitoring and Metabolic Control as well as Treatment Satisfaction in Outpatients With Diabetes Type 1. Exp Clin Endocrinol Diabetes. 2021;129(4):303-308. Epub 2019 Jun 11.
Kloos C, Burghardt K, Müller UA, Kramer G, Müller N, Wolf G, Kuniss N. Reduction of Severe Hypoglycaemia in People with Type 2 Diabetes after a Structured Inpatient Intervention. Exp Clin Endocrinol Diabetes. 2019 Sep 5. [Epub ahead of print]
Roth J, Müller N, Kuniss N, Wolf G, Müller UA. Association Between Glycaemic Control and the Intake of Thiazide Diuretics, Beta Blockers and Levothyroxine in People Without Diabetes. Exp Clin Endocrinol Diabetes. 2019. [Epub ahead of print]
K Burghardt, UA Müller, N Müller, C Kloos, G Kramer, V Jörgens, N Kuniss. Adequate structured inpatient diabetes intervention in people with type 1 diabetes improves metabolic control and frequency of hypoglycaemia. Exp Clin Endocrinol Diabetes. 2019. [Epub ahead of print]
Guido Kramer, Nadine Kuniß, Gunter Wolf, Christof Kloos. Diabetologische Tagesklinik und Kompetenzzentrum für Diabetestechnologie am Universitätsklinikum Jena ergänzen komplementär ambulante Versorgungsstrukturen für Menschen mit Diabetes mellitus. Ärzteblatt Thüringen, 9/2020.
Peter Kronsbein, Nadine Kuniß. CME-Fortbildung: Strukturierte Diabetes-Schulung / Structured Diabetes Education. Diabetologie und Stoffwechsel 2020; 15(04): 287-304. DOI: 10.1055/a-0895-7607
Ulf Zitterbart, Nadine Kuniss. SARS-COV2 – Wie die Klassikerstadt Weimar früh mit Hilfe von Haus- und Kinderärzten und deren Praxispersonal Verdachtsfälle auf COVID-19 verifiziert – Erfahrungsbericht. Thüringer Ärzteblatt: Ausgabe 5/2020, S. 30 – 32.
Mertes B, Gödde S, Piorkowski M, Kramer G, Müller UA, Kuniss N. Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years. J Clin Med. 2020; 9(4):1153.
Arend F, Müller UA, Schmitt A, Voigt M, Kuniss N. Overestimation of Risk and Increased Fear of Long-term Complications of Diabetes in People with Type 1 and 2 Diabetes.
Exp Clin Endocrinol Diabetes. 2019 Oct;127(10):645-652.
Kuniss N, Müller UA, Kloos C, Jörgens V, Kramer G. Diabetes-related distress is reduced in people with type 1 but not type 2 diabetes after participation in a diabetes treatment and teaching programme. Diabetes Metab. 2019; 45(3):310-312.
H Schübert, U A Müller, G Kramer, N Müller, T Heller, C Kloos, N Kuniss. Snacking is Common in People with Diabetes Type 1 and Type 2 with Insulin Therapy and Is Not Associated With Metabolic Control or Quality of Life. Exp Clin Endocrinol Diabetes. 2019; 127(7):461-467.
Kuniss N, Freyer M, Müller N, Kielstein V, Müller UA. Expectations and fear of diabetes-related long-term complications in people with type 2 diabetes at primary care level. Acta Diabetologica 2019, 56(1):33-38.
Masuch A, Friedrich N, Roth J, Nauck M, Müller UA, Petersmann A (2019) Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts.BMC Endocr Disord. 2019 Feb 12;19(1):20. doi: 10.1186/s12902-019-0338-7.
Werner C, Müller N, Müller UA (2019) Agonistic autoantibodies against B2-adrenergic receptors correlating with macrovascular disease in longstanding diabetes type 2. Acta Diabetol. 2019 Feb 15. doi: 10.1007/s00592-019-01296-8. [Epub ahead of print]
Roth J, Müller N, Lehmann T, Böer K, Löbel S, Pum J, Müller UA (2018) Comparison of HbA1c Measurements using 3 Methods in 75 Patients Referred to One Outpatient Department. Exp Clin Endocrinol Diabetes. 2018 Jan;126(1):23-26.
Heller T, Kloos C, Lehmann T, Schiel R, Lorkowski S, Wolf G, Müller UA, Müller N (2018) Mortality and its Causes in a German Cohort with Diabetes Mellitus Type 1 after 20 Years of Follow-Up: The JEVIN Trial. Exp Clin Endocrinol Diabetes. 2018 Jun;126(6):387-393.
Viktor Jörgens, Nadine Kuniß. Patientenschulung – Erneute Schulung erfolgreich!. Diabetes Forum. Kirchheim-Verlag 06/2018
Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner K, Landgraf R, Merker L, Müller UA, Müller-Wieland D, Niederau C, Roth J, Spannagl M, Wallaschofski H, Nauck M (2018) HbA1c measurement in Germany: Is the quality sufficient for follow-up and diagnosis? Diabetologie 2018; 13: 1–7.
Werner C, Lupp A, Kloos C, Freesmeyer M, Mireskandari M, Stoykow C, Bauschke A, Müller UA (2018) Proinsulin only secreting adenoma, only visible in GLP-1 Receptor PET-CT. J Med Imaging Radiat Oncol. 2018 Jun;62(3):370-374. doi: 10.1111/1754-9485.12704. Epub 2018 Feb 5.
Werner C, Müller N, Müller UA (2018) Agonistic Autoantibodies against adrenergic receptors correlating with antihypertensive therapy in longstanding diabetes type 2. Acta Diabetol. 2018 Mar;55(3):301-303. doi: 10.1007/s00592-018-1100-8. Epub 2018 Jan 18.
Burghardt K, Kaemmerer D, Michael A, Aschenbach R, Müller UA, Kloos C, Wolf G (2018) Successful endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma in a patient with severe comorbidities not suitable for pancreatic surgery. Diabetes Metab. 2018 Feb;44(1):84-86. doi: 10.1016/j.diabet.2016.12.012. Epub 2017 Feb 1.
Askitis D, Tsitlakidis D, Müller N, Waschke A, Wolf G, Müller UA, Kloos C (2018) Complete evaluation of pituitary tumours in a single tertiary care institution. Endocrine 60(2):255-262. doi: 10.1007/s12020-018-1570-z. Epub 2018 Mar 12.
Petersmann A, Nauck M, Müller-Wieland D1, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L (2018) Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2018 Jul;126(7):406-410. doi: 10.1055/a-0584-6223. Epub 2018 Jul 5.
Petermann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L (2018) Definition, Classification and Diagnostics of Diabetes Mellitus. Journal of Laboratory Medicine. 42, 73–79
Müller UA, Farker K, Kerner W, Mühlbauer B (2018) Sulfonylureas for therapy of type 2 diabetes. Arzneiverordnung in der Praxis 45, Juli 2018, 116-122.
Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, Merker L, Müller UA, Müller-Wieland D, Roth J, Spannagl M, Wallaschofski H, Nauck M (2018) Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany. Horm Metab Res. 2018 Sep 14. doi: 10.1055/a-0721-2273.
Landgraf R, Nauck M, Freckmann G, Müller UA, Heinemann L, Kellerer M, Müller-Wieland D (2018) Pitfalls in the Diagnosis of Diabetes: Are we too Lax with Laboratory Parameters? Dtsch Med Wochenschr. 2018 Sep 20.
Dorenkamp M, Müller JP, Shanmuganathan KS, Schulten H, Müller N, Löffler I, Müller UA, Wolf G, Böhmer FD, Godfrey R, Waltenberger J (2018) Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis. Sci Rep. 2018 Oct 2;8(1):14684.
Buhse S, Kuniss N, Liethmann K, Müller UA, Lehmann T, Mühlhauser I. (2018) An informed shared decision making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial. BMJ Open. 2018 Dec 14;8(12):e024004.
Voigt M, Heller T, Hagen B, Müller UA (2018) Epidemiologie der diabetischen Retinopathie. Prävalenz, Progression, Sehverschlechterung und Erblindung in Deutschland. Diabetologe (2018).
Nauck M, Petersmann A, Müller-Wieland D, Schleicher E, Müller UA, Landgraf R, Freckmann G, Heinemann L (2018) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie 2018; 13 (Suppl 2): S90–S96.
Susanne Buhse, Nadine Kuniss, Kathrin Liethmann, Ulrich Alfons Müller, Thomas Lehmann, Ingrid Mühlhauser. Informed shared decision-making programme for patients with type 2 diabetes in primary care: cluster randomised controlled trial. BMJ Open 2018, 8(12):e024004.
K Reise, V Hartung, UA Müller, N Müller, C Kloos, T Lehmann, G Wolf, N Kuniss. Prevalence and Influencing Factors of Mild Hypoglycaemia in People with Diabetes Type 1 and Type 2 in a Tertiary Care Centre: A Cross-Sectional Study. Curre Res Diabetes & Obes J. 2018; 6(3): 555689.
Kellner C, Kuniss N, Kloos C, Müller UA, Müller N. No selection, but higher satisfaction of people participating in the disease management programme diabetes type 2 in Germany.
Acta Diabetol. 2018;55(4):363-367.
Kuniss N, Müller UA, Kloos C, Müller R, Starrach G, Jörgens V, Kramer G. Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting. Acta Diabetol, 2018;55(2):131-137.
Nadine Kuniss, Ulrich Alfons Müller, Christof Kloos, Gunter Wolf, Guido Kramer. Reduction of HbA1c and diabetes-related distress after intervention in a diabetes day care clinic in people with type 2 diabetes but not with type 1 diabetes. Exp Clin Endocrinol Diabetes, 2018; 126:242-248.
- Kuniss, T. Rechtacek, C. Kloos, U. A. Müller, J. Roth, K. Burghardt, G. Kramer. Diabetes-related burden and distress in people with diabetes mellitus at primary care level in Germany. Acta Diabetol 2017;54(5):471-478.
Müller N, Lehmann T, Gerste B, Adler JB, Kloos C, Hartmann M, Kramer G, Kuniss N, Müller UA. Increase in the incidence of severe hypoglycaemia in people with Type 2 diabetes in spite of new drugs: analysis based on health insurance data from Germany. Diabet Med. 2017;34(9):1212-1218.
Nauck MA, Petermann A, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, Freckmann G, Heinemann L (2017) (2017) Praxisleitlinie Klassifikation und Diagnose des Diabetes mellitus. Diabetologie 12(Suppl 2):S94-S100.
Voigt M, Schmidt S, Lehmann T, Köhler B, Kloos C, Voigt UA, Meller D, Wolf G, Müller UA, Müller N (2017) Prevalence and progression of diabetic retinopathy in people with type 2 diabetes dependent on the duration of diabetes. Exp Clin Endocrinol Diabetes. 2017 Nov 28.
Müller UA (2017) Treating postprandial blood sugar spikes: beneficial or merely blood sugar cosmetics? Diabetologe 13: 427.
Heller T, Reise K, Roth J, Lehmann T, Schiel R, Lorkowski S, Müller UA, Müller N (2017) Changes in Quality of Diabetes Care and Morbidity over 20 Years in People with Type 1 Diabetes and Long Diabetes Duration: The JEVIN Trial. Exp Clin Endocrinol Diabetes. 125:122-129.
Müller N, Khunti K, Kuss O, Lindblad U, Nolan JJ, Rutten GE, Trento M, Porta M, Roth J, Charpentier G, Jörgens V, Müller UA (2017) Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol. 54:209-214.
